A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

EXCLUSIVE: Retired David Mather was dealt a shocking blow when told his tiredness was stage-IV lung cancer - now a new UK ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

In this video, Aruna Padmanabhan, MD, discusses the effectiveness of cyclin-dependent kinase inhibitors in the treatment of metastatic hormone-positive breast cancer.

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The Scottish Medicines Consortium (SMC) gave the green light to three new cancer treatments, as well as a drug to help ...